The Independent Review Entity (IRE), explained
Checked against the current rules on September 18, 2026.
The Independent Review Entity is a separate company under contract with CMS — not part of your Medicare Advantage plan — that reviews cases the plan didn't fully approve at reconsideration.
Source: 42 CFR Part 422, Subpart M — Grievances, Organization Determinations and Appeals.
The IRE reviews the case independently of the plan and issues its own decision, which can affirm, reverse, or partially reverse the plan's reconsideration.42 CFR 422.592
Most delays at this level are administrative, not a sign anything is wrong with the case — having your case number ready when you call gets a faster, more specific status update.CMS Guidance § 60.3
Why this level matters
By the time a case reaches the IRE, it has already been reviewed once by the plan itself — this is the first review by an organization with no financial stake in the outcome, which is a meaningfully different kind of scrutiny than a plan reconsidering its own decision.
The IRE's decision is also the point at which the case becomes eligible to move further — to an ALJ hearing — once the amount-in-controversy threshold is met, so an IRE denial isn't a dead end even when it upholds the plan.
You don't file anything to reach the IRE — the plan is required to forward the case automatically once it upholds its own denial at reconsideration, or fails to decide the reconsideration in time. If you believe your case should have been forwarded and hasn't been, that's worth a direct call, since an automatic step that silently doesn't happen is a real, correctable error, not something to simply wait out.
The IRE's own decision letter will explain, in writing, the basis for its ruling and cite the specific Medicare rule it applied — reading that letter carefully is worth it even when the outcome is unfavorable, since it tells you exactly what an ALJ would also be looking at if the case goes further.
Like reconsideration, the IRE level is a genuine fresh review — new evidence submitted at this stage is considered, not just whatever the plan originally had on file.
Unlike a plan's own reconsideration, the IRE has no ongoing relationship with the plan and no financial incentive tied to the outcome — its only role is to apply the Medicare rule correctly.
Sources — last checked September 18, 2026
- 42 CFR 422.592as of September 18, 2026
- CMS Guidance § 60.3as of July 6, 2026
Related
Not sure what applies to your case?
Upload your denial letter and get a free, plain-language explanation with your real deadline.
By CaseWhy Appeals editorial. See how this content is produced. Not legal advice. Not affiliated with or endorsed by Medicare, CMS, or any health plan. A product of CaseWhy LLC.